Kaymak Cihan Meriç, Ünver Korğalı Elif
Division of Pediatric Hematology and Oncology, Department of Pediatrics, Cumhuriyet University Faculty of Medicine, Sivas, Turkey.
Department of Pediatric Hematology and Oncology, Dr. Abdurrahman Yuraslan Ankara Oncology Training and Education Hospital, Ankara, Turkey.
Arch Argent Pediatr. 2018 Dec 1;116(6):e736-e743. doi: 10.5546/aap.2018.eng.e736.
Vitamin D (VitD) affects the erythropoiesis. The aim of this study was to evaluate the association between maternal/child 25-OH VitD (25-OHD) levels and iron deficiency (ID) and anemia (IDA) in children aged 6 months-5 years.
Between September 2014 and January 2016 children who were admitted to outpatient clinic were included to study. We excluded the children with acute or chronic infection, malnutrition, chronic disease and preterm birth history. Complete blood count, serum iron, total iron binding capacity, ferritin, 25-OHD levels were examined from children and their mothers. Iron and VitD supplementation during infancy and pregnancy and breastfeeding history were questioned.
The study included totally 117 children. There were 67 children with ID/IDA [Group 1, mean age (years):2.05±1.24 (0.5-5)] and 50 normal children [Group 2, mean age (years): 1.87±1.12 (0.58-5)]. There were more VitD deficient children and mothers in Group 1 than in Group 2 (respectively, children 49.3 % vs. 20 % p=0.002; mothers 94 % vs.64 %, p=<0.001). There was a positive correlation between hemoglobin levels of children and maternal/child 25-OHD.The independent risk factors for IDA in children were longer exclusively breastfeeding time (odds ratio [OR], 0.35; 95 % confidence interval [CI], 0.1550.789; p=0.011), shorter duration of regular iron supplementation during infancy and pregnancy (infancy: OR,1.69; 95 % CI 1.148-2.508; p=0.008. pregnancy: OR,1.39; 95 % 0,1.070-1.820; p=0.014) and lower maternal 25-OHD level (OR,1.16; 95 % 0,1.034-1.292; p=0.011).
Maternal/child VitD deficiency is associated with ID/IDA in children aged 6 months-5 years.
维生素D(VitD)影响红细胞生成。本研究旨在评估6个月至5岁儿童的母体/儿童25-羟基维生素D(25-OHD)水平与缺铁(ID)及贫血(IDA)之间的关联。
2014年9月至2016年1月期间,门诊收治的儿童纳入研究。排除患有急慢性感染、营养不良、慢性疾病及有早产史的儿童。检测儿童及其母亲的全血细胞计数、血清铁、总铁结合力、铁蛋白、25-OHD水平。询问婴儿期、孕期铁和VitD补充情况及母乳喂养史。
本研究共纳入117名儿童。其中67名患有ID/IDA[第1组,平均年龄(岁):2.05±1.24(0.5 - 5)],50名正常儿童[第2组,平均年龄(岁):1.87±1.12(0.58 - 5)]。第1组中VitD缺乏的儿童和母亲比第2组更多(儿童分别为49.3%对20%,p = 0.002;母亲分别为94%对64%,p < 0.001)。儿童血红蛋白水平与母体/儿童25-OHD之间存在正相关。儿童IDA的独立危险因素为纯母乳喂养时间较长(优势比[OR],0.35;95%置信区间[CI],0.155 - 0.789;p = 0.011)、婴儿期和孕期定期补铁时间较短(婴儿期:OR,1.69;95% CI 1.148 - 2.508;p = 0.008。孕期:OR,1.39;95% CI 1.070 - 1.820;p = 0.014)以及母体25-OHD水平较低(OR,1.16;95% CI 1.034 - 1.292;p = 0.011)。
6个月至5岁儿童的母体/儿童VitD缺乏与ID/IDA相关。